The analysis can examine different genetic features depending on the testing goal. DNA-based testing may identify a particular inherited variant, whereas chromosome analysis evaluates whether embryos have abnormal chromosome copy numbers. These findings answer different biological questions: one concerns transmission of a specific genetic change, while the other concerns broader chromosomal balance during early development.
A screening result describes selected genetic or chromosomal features detected in the tested cells, but it does not establish that implantation will occur or that a healthy birth will follow. Reproductive outcomes therefore cannot be inferred from screening alone. This limitation is important when interpreting results and considering how they may inform embryo selection decisions.
A small number of cells are removed from an embryo developed through in vitro fertilization while the embryo remains in culture. Those cells provide material for DNA or chromosome analysis, allowing testing without treating the entire embryo as the analytical sample. The procedure connects laboratory measurement with decisions about which embryos may be considered for implantation.
The workflow begins with embryo development through in vitro fertilization, followed by collection of a small cell sample. The sample is then analyzed for DNA features or chromosome copy number while the embryo remains in culture. Results can identify embryos carrying particular inherited variants or abnormal chromosome numbers, supplying information for subsequent reproductive decisions.
In biology, these approaches support investigation of early development, genome stability, and inheritance. Comparing genetic or chromosomal findings among embryos can help researchers examine how genomic features relate to embryo development and selection. The same laboratory framework therefore contributes both to reproductive decision-making and to broader studies of biological processes occurring early in development.
Using genetic and chromosomal information in embryo selection raises questions about how findings should be interpreted, which abnormalities or inherited variants warrant consideration, and how much weight laboratory results should receive. These issues accompany the scientific limitations of screening, because the tests provide selected information rather than certainty about implantation or a healthy birth.